Opponents have accused Johnson & Johnson of “vote-rigging” in its latest efforts to resolve thousands of lawsuits alleging its baby powder causes ovarian cancer.
On Tuesday, the company faces a critical test over its $10bn proposal to end the litigation, as it tries to convince a judge to sign off on its third attempt to resolve the lawsuits through a subsidiary’s bankruptcy.
US Bankruptcy Judge Christopher Lopez in Houston will decide the fate of J&J’s latest Chapter 11 bid ;after a weeks-long court hearing weighing competing demands to approve the settlement or end the bankruptcy altogether, reports Reuters.
The company is attempting to use a subsidiary’s bankruptcy to resolve lawsuits from more than 62 000 plaintiffs alleging its baby powder and other talc products were contaminated with asbestos and caused ovarian and other cancers, a claim that J&J denies.
Courts have rejected J&J’s two previous efforts to resolve the talc litigation through a subsidiary’s bankruptcy, but the company is trying again in a different bankruptcy court. It says the third effort can succeed where the others faltered because its subsidiary, Red River Talc, now has votes showing a broad level of support for its settlement proposal.
Opponents of the deal say the vote was rigged to ensure J&J’s preferred outcome.
Adam Silverstein, an attorney representing plaintiffs who oppose the bankruptcy deal, said that J&J challenged every vote against its plan, while blindly accepting votes in its favour.
J&J allowed votes to be changed from “no” to “yes” but ignored an attorney who sought to change his votes from “yes” to “no”, Silverstein said. The company also violated its own voting rules to accept “yes” votes from attorneys who could not produce medical records or could not show that they had authority to vote on their clients’ behalf, he added.
Lopez will consider evidence on a wide range of topics, including the validity of the votes that J&J gathered last year and whether such a wealthy company should be able to use a subsidiary’s bankruptcy to protect itself from lawsuits.
The current court hearing will last until the end of February.
J&J believes bankruptcy offers a faster and fairer way to put money into the hands of cancer victims, who would otherwise face lengthy legal battles in a “lottery-like” court system that results in large verdicts for some plaintiffs and nothing for others.
Erik Haas, J&J’s vice-president for litigation, said in a statement that the bankruptcy proposal has “overwhelming support” from cancer victims and “affords claimants a far better recovery than they stand to recover at trial”.
However, opponents of the deal argue that the bankruptcy settlement should not bind those who do not like the terms and would prefer to take their chances in court.
They said that by pushing the deal through a subsidiary’s bankruptcy, J&J is trying to force women with ovarian cancer to accept lower settlement payments based on a deeply flawed vote.
Reuters article – J&J begins crucial battle over $10 billion baby powder settlement (Open access)
See more from MedicalBrief archives:
Johnson & Johnson's appeal on $2.12bn talc verdict dismissed
Judge foils bid to block J&J bankruptcy plan
Cancer victims want J&J talc bankruptcy blocked by courts
Californian jury awards $29m in Johnson & Johnson talc/cancer case